News|Articles|November 11, 2025
Biomarker-Specific De Novo Assay Creation
Key Takeaways
De novo assay development holds great promise for future drug discovery projects, potentially reducing costs, improving success rates, and ultimately benefiting patients by accelerating the development of safe and effective therapeutics. Learn what you need to know with regard to new biomarker assay development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Biopharma Navigates the 2026 Economic Shift
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
5